Novo Nordisk A/S (NYSE:NVO)

55.17
Delayed Data
As of 1:08pm ET
 +0.41 / +0.75%
Today’s Change
41.72
Today|||52-Week Range
58.21
+30.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues4.0B3.9B4.1B3.7B
 
 
 
 
 
Cost of Goods Sold553.0M472.2M589.9M477.0M
 
 
 
 
 
Depreciation And Amortization122.8M128.5M74.4M98.5M
 
 
 
 
 
 
Operating ExpensesGross Income3.3B3.3B3.4B3.2B
 
 
 
 
 
General Expenses1.7B1.8B1.9B1.5B
 
 
 
 
 
Other Operating Expenses0.000.00-79.7M0.00
 
 
Research And Development566.0M640.7M642.1M482.8M
 
 
 
 
 
Total Operating Expenses2.4B2.4B2.5B2.1B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.6B1.5B1.6B1.6B
 
 
 
 
 
Extraordinary Credit----0.00353.0M
 
 
Extraordinary Charge-----79.7M--
 
 
Interest Expense On Debt25.8M77.3M--246.1M
 
 
 
 
Other Expenses110.4M86.8M-103.5M102.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.7B1.5B1.4B1.9B
 
 
 
 
 
Income Taxes-367.2M-342.6M---387.6M
 
 
 
 
Net Income1.3B1.1B1.1B1.5B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.6B2.6B2.6B2.6B
 
 
 
 
 
Shares To Calculate EPS Diluted2.6B2.6B2.6B2.6B
 
 
 
 
 
 
Earnings Per ShareEPS$0.49$0.44$0.42$0.56
 
 
 
 
 
EPS Diluted$0.49$0.43$0.42$0.56
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account